STRATA Skin Sciences, Inc.

SSKN

STRATA Skin Sciences, Inc.

SSKN

Insider Sentiment (TTM):

Last Purchase:2025-11-18Last Sale:2025-11-17Shares Purchased (TTM):5,000Shares Sold (TTM):14,094

Institutional Sentiment:

As of:2025-12-31Institutional Shares Owned:1,090,274Shares Outstanding:4,650,556Institutional Ownership Pct.:23.44%

Earnings Market Reaction:

Filing Date:2026-03-26Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	8	7	6	7	7	7	5	5	7	7	9	3
Restricted Cash Current	0	0	0	1	1	1	1	1	1	1	1	1
Accounts Receivable Net Current	4	4	4	5	5	4	4	4	4	5	4	4
Inventory Net	3	3	3	3	2	3	3	3	3	6	6	6
Prepaid Expense And Other Assets Current	1	1	1	0	1	0	0	0	0	0	1	1
Assets Current	16	14	14	16	17	16	14	13	16	20	21	15
Property Plant And Equipment Net	9	10	9	9	10	10	11	12	12	8	8	8
Operating Lease Right Of Use Asset	1	1	1	1	1	1	1	2	1	1	1	1
Intangible Assets Net Excluding Goodwill	3	4	4	5	5	6	6	7	7	10	16	17
Goodwill	1	1	3	3	1	6	7	7	7	9	9	9
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Assets	31	31	31	34	35	39	40	40	42	47	55	49
Liabilities And Stockhold…
Liabilities Current
Long Term Debt Current	15	2	-	-	0	-	-	-	-	-	-	-
Accounts Payable Current	3	3	3	3	2	2	3	4	3	3	4	3
Accrued Liabilities Current	6	6	7	9	7	8	7	6	6	6	7	7
Contract With Customer Liability Current	2	3	2	2	2	2	2	2	2	2	2	3
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Asset Acquisition Contingent Consideration Liabili…	0	1	1	1	1	1	0	0	0	0	1	0
Liabilities Current	27	15	14	15	13	13	12	13	12	12	14	13
Long Term Debt Noncurrent	0	13	15	15	15	15	15	15	15	15	15	8
Deferred Income Tax Liabilities Net	-	-	-	-	0	0	0	0	0	0	0	0
Other Liabilities And Deferred Revenue Noncurrent	0	0	0	0	0	0	0	0	1	1	1	0
Operating Lease Liability Noncurrent	1	1	1	1	1	1	1	1	0	0	0	0
Asset Acquisition Contingent Consideration Liabili…	0	0	0	0	0	0	1	1	1	3	8	8
Liabilities	28	29	30	32	30	30	30	31	29	31	38	30
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	257	256	253	253	253	253	251	251	251	250	250	249
Retained Earnings Accumulated Deficit	-254	-254	-253	-251	-248	-244	-242	-241	-238	-234	-233	-230
Stockholders Equity	3	1	0	3	5	9	9	9	13	16	17	19
Liabilities And Stockholders Equity	31	31	31	34	35	39	40	40	42	47	55	49
Allowance For Doubtful Accounts Receivable Current	1	1	1	1	0	0	0	0	0	0	0	0
Preferred Stock Par Or Stated Value Per Share	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	150	150	150	150	150	150	150	150	150	150	150	150
Common Stock Shares Issued	6	5	4	4	4	4	4	4	4	3	3	3
Shares Outstanding	6	5	4	4	4	4	4	4	4	3	3	3

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2025	-9.33%	-13.06%	-27.24%	-1.66%	16.57%	-1.66%	5.88%	-6.62%	-11.03%	-32.05%	-51.24%	-51.64%
2024	-25.71%	-26.42%	-16.67%	16.77%	-5.77%	5.34%	-4.34%	-1.29%	-12.26%	-5.95%	-1.49%	-15.85%
2023	-15.23%	-4.28%	-13.33%	-26.14%	-32.39%	-39.50%	72.00%	1689.06%	1579.69%	44.18%	4.13%	-17.99%
2022	-	-	-	-	-	-	-	-	-	6.73%	-10.27%	-13.54%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Liquidity Ratios
Current Ratio	0.58	0.95	0.98	1.05	1.24	1.21	1.14	1.05	1.28	1.64	1.50	1.11
Quick Ratio	0.45	0.70	0.71	0.85	1.03	0.98	0.89	0.81	1.03	1.10	1.05	0.62
Working Capital	-11.14M	-761.00K	-230.00K	737.00K	3.20M	2.72M	1.69M	651.00K	3.37M	7.70M	7.13M	1.45M
Leverage & Debt
Debt to Equity	9.50	22.38	98.75	11.84	6.02	3.19	3.17	3.25	2.31	1.91	2.26	1.54
Interest Coverage TTM	-2.40	-4.87	-4.99	-4.05	-4.39	-3.97	-3.52	-4.74	-5.25	-3.63	-4.71	-4.87
Debt Ratio	0.90	0.96	0.99	0.92	0.86	0.76	0.76	0.76	0.70	0.66	0.69	0.61
Efficiency & Turnover
Asset Turnover TTM	0.94	0.88	0.93	0.90	0.87	0.75	0.69	0.73	0.71	0.70	0.66	0.70
Days Sales Outstanding TTM	55.73	46.81	44.45	46.88	52.71	51.64	46.73	42.45	48.75	43.76	37.64	34.38
Receivables Turnover TTM	6.55	7.80	8.21	7.79	6.92	7.07	7.81	8.60	7.49	8.34	9.70	10.62
Per Share Metrics
Diluted EPS TTM	-1.35	-2.47	-2.77	-2.19	-2.65	-2.31	-2.37	-3.24	-3.10	-2.06	-2.05	-1.69
Free Cash Flow Per Share TTM	-0.94	-0.81	-0.70	-0.16	-0.38	-0.49	-1.10	-1.38	-1.70	-2.03	-1.75	-1.79
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	58.25%	58.15%	58.20%	58.86%	57.27%	55.53%	54.42%	52.71%	55.34%	58.14%	59.59%	60.04%
Operating Profit Margin TTM	-15.31%	-31.27%	-30.81%	-24.93%	-27.58%	-25.77%	-22.70%	-27.37%	-25.79%	-14.26%	-14.51%	-13.44%
Net Profit Margin TTM	-20.40%	-35.79%	-35.13%	-27.22%	-30.05%	-28.57%	-25.40%	-34.91%	-32.47%	-20.40%	-19.92%	-16.03%
Growth Metrics
Net Revenue Growth (1Y)	-8.54%	-5.19%	0.36%	3.30%	0.61%	-7.36%	-8.66%	-11.29%	-7.75%	1.89%	8.87%	17.62%
Net Income Growth (1Y)	-37.92%	18.78%	38.80%	-19.48%	-6.87%	29.72%	16.48%	93.18%	95.17%	15.36%	23.84%	110.82%
EPS Growth (1Y)	-49.18%	7.05%	16.67%	-32.32%	-14.58%	12.13%	15.88%	92.09%	94.01%	14.74%	23.28%	109.72%
Valuation Metrics
P/E TTM	-0.94	-0.83	-0.83	-1.20	-1.10	-1.19	-1.29	-1.17	-0.18	-0.29	-0.46	-0.63
P/B TTM	2.02	7.03	31.01	4.13	2.23	1.18	1.13	1.41	0.15	0.13	0.20	0.19
P/S TTM	0.19	0.30	0.29	0.33	0.33	0.34	0.33	0.41	0.06	0.06	0.09	0.10
Market Cap	5.86M	9.23M	9.55M	11.01M	11.08M	11.11M	10.76M	13.25M	1.92M	2.08M	3.31M	3.69M
Enterprise Value	13.30M	17.47M	18.86M	18.40M	17.68M	17.86M	19.06M	23.09M	8.85M	9.96M	9.27M	8.38M
Calculated Values
Free Cash Flow TTM	-4.38M	-3.63M	-2.92M	-668.00K	-1.45M	-1.99M	-3.84M	-4.85M	-5.93M	-7.10M	-6.11M	-6.24M
Net Debt	7.44M	8.23M	9.30M	7.39M	6.60M	6.76M	8.30M	9.84M	6.93M	7.89M	5.95M	4.69M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-11-18Purchase

Owner: Rubinstein, Samuel

Title: -

Shares: 5,000

Price/Share: $1.40

Value: $7,000.00

Shares Owned: 8,766

Relationship: Director

Ownership: Direct

2025-11-17Sale

Owner: Rubinstein, Samuel

Title: -

Shares: 14,094

Price/Share: $1.34

Value: $18,885.96

Shares Owned: 3,766

Relationship: Director

Ownership: Direct

2024-07-15Purchase

Owner: Geiger, Uri

Title: -

Shares: 230,573

Price/Share: $3.14

Value: $723,999.22

Shares Owned: 1,441,835

Relationship: Director,TenPercentOwner

Ownership: Indirect

2024-07-15Purchase

Owner: Rafaeli, Dolev

Title: Chief Executive Officer

Shares: 19,100

Price/Share: $3.14

Value: $59,974.00

Shares Owned: 143,156

Relationship: Director,Officer

Ownership: Direct

2024-07-15Purchase

Owner: Accelmed, Growth Partners…

Title: -

Shares: 230,573

Price/Share: $3.14

Value: $723,999.22

Shares Owned: 1,441,835

Relationship: TenPercentOwner

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-11-18	Rubinstein, Samuel	Director	-	Direct	Purchase	5,000	1.40	$7,000.00	8,766	4
2025-11-17	Rubinstein, Samuel	Director	-	Direct	Sale	14,094	1.34	$18,885.96	3,766	4
2024-07-15	Geiger, Uri	Director,TenPercentOwner	-	Indirect	Purchase	230,573	3.14	$723,999.22	1,441,835	4
2024-07-15	Rafaeli, Dolev	Director,Officer	Chief Executive Officer	Direct	Purchase	19,100	3.14	$59,974.00	143,156	4
2024-07-15	Accelmed, Growth Partners…	TenPercentOwner	-	Direct	Purchase	230,573	3.14	$723,999.22	1,441,835	4
2023-12-01	Gov, Shmuel	Officer	COO	Direct	Purchase	20,000	0.46	$9,200.00	20,000	4
2023-11-16	Rubinstein, Samuel	Director	-	Direct	Sale	1,000	0.32	$320.00	177,602	4
2023-08-16	22Nw, Gp, Inc., 22Nw, Lp,…	TenPercentOwner	-	Indirect	Purchase	1,853,056	0.55	$1,019,180.80	5,369,954	4
2023-08-10	Moccia, Robert Joseph	Director,Officer	Chief Executive Officer	Direct	Purchase	42,000	0.67	$28,140.00	235,300	4
2023-08-10	Lesovitz, Christopher	Officer	Chief Financial Officer	Direct	Purchase	15,151	0.68	$10,302.68	38,282	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2025-12-31

23.44%

Inst. Shares: 1,090,274

Shares Outstanding: 4,650,556

2025-09-30

25.72%

Inst. Shares: 1,152,469

Shares Outstanding: 4,481,337

2025-06-30

28.96%

Inst. Shares: 1,208,045

Shares Outstanding: 4,171,161

2025-03-31

29.25%

Inst. Shares: 1,219,930

Shares Outstanding: 4,171,161

2024-12-31

32.03%

Inst. Shares: 1,219,267

Shares Outstanding: 3,807,186

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2025-12-31	1,090,274	4,650,556	23.44%
2025-09-30	1,152,469	4,481,337	25.72%
2025-06-30	1,208,045	4,171,161	28.96%
2025-03-31	1,219,930	4,171,161	29.25%
2024-12-31	1,219,267	3,807,186	32.03%
2024-09-30	1,207,113	4,038,988	29.89%
2024-06-30	1,066,543	3,506,025	30.42%
2024-03-31	1,007,236	3,506,025	28.73%
2023-12-31	1,029,685	3,491,964	29.49%
2023-09-30	1,059,997	3,491,113	30.36%
2023-06-30	1,011,884	3,488,081	29.01%
2023-03-31	1,005,647	3,486,209	28.85%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

STRATA Skin Sciences, Inc. (SSKN) — SEC Financial Statements & Analysis

STRATA Skin Sciences, Inc. (SSKN) is a surgical & medical instruments & apparatus company, incorporated in DE. STRATA Skin Sciences, Inc. trades on OTC as: SSKN. Based on its latest SEC filing (Form 10-Q, period ending 2025-12-31), STRATA Skin Sciences, Inc. reported a -8.54% year-over-year revenue growth, a Gross Profit Margin of 58.25% (TTM), a Debt-to-Equity ratio of 9.50x, a Price-to-Sales (P/S) ratio of 0.19x (TTM), a Price-to-Book (P/B) ratio of 2.02x (TTM), at a market cap of $5.86M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -8.54%
Gross Profit Margin TTM: 58.25%
Debt To Equity: 9.50x
P/S TTM: 0.19x
P/B TTM: 2.02x
Market Cap: $5.86M

Data as of 2025-12-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is STRATA Skin Sciences, Inc. in?

STRATA Skin Sciences, Inc. (SSKN) operates in the Surgical & Medical Instruments & Apparatus industry.

What is SSKN's market cap?

STRATA Skin Sciences, Inc. (SSKN) has a market capitalization of $5.86M as of 2025-12-31.

What exchange does SSKN trade on?

STRATA Skin Sciences, Inc. (SSKN) trades on the OTC.

Where is STRATA Skin Sciences, Inc. incorporated?

STRATA Skin Sciences, Inc. is incorporated in DE.